Summary
Ulcerative colitis (UC) is an autoimmune related disease that causes inflammation and sores, called ulcers, in the lining of the rectum and colon. It is one of a group of diseases called inflammatory bowel disease. UC can happen at any age, but it usually starts between the ages of 15 and 30. It tends to run in families. The most common symptoms are pain in the abdomen and blood or pus in diarrhea. Other symptoms may include, anemia, severe tiredness, weight loss, loss of appetite, bleeding from the rectum, sores on the skin, joint pain, and growth failure in children. About half of people with UC have mild symptoms. Doctors use blood tests, stool tests, colonoscopy or sigmoidoscopy, and imaging tests to diagnose UC. Several types of drugs can help control it. Some people have long periods of remission, when they are free of symptoms. In severe cases, doctors must remove the colon.
From the Autoimmune Association.
Symptoms
Ulcerative colitis symptoms can vary, depending on the severity of inflammation and where it occurs. Signs and symptoms may include:
Diarrhea, often with blood or pus
Rectal bleeding — passing small amount of blood with stool
Abdominal pain and cramping
Rectal pain
Urgency to defecate
Inability to defecate despite urgency
Weight loss
Fatigue
Fever
In children, failure to grow
Most people with ulcerative colitis have mild to moderate symptoms. The course of ulcerative colitis may vary, with some people having long periods when it goes away. This is called remission.
From the Autoimmune Association.
Diagnostic Criteria
Under Investigation
Study Classification Criteria
Under Investigation
Diagnostic Tests
Under Investigation
Organized Autoimmunity
(Alternative Autoimmune Disease Classification: FIEM, MIEM or BIEM, or FEM, MEM or BEM)
sex predominance (is an autoimmune disease primarily found in genetic Females, Males, or equally in Both?)
Under Investigation
Inherited and acquired gene variations that cause increased susceptibility
Human Leukocyte Antigen (HLA) Associations
Under Investigation
Other Gene Variations (mutations)
Under Investigation
Gene Triggering Environmental Exposures
Infections
COVID-19 (Chang et. al, 2023, found a significantly higher risk of inflammatory bowel disease following COVID-19 infection in a study of 3,814,479 participants)
Toxins
Under Investigation
Stress
Needs to be assessed for each patient
Multiple interactive and destructive immune system pathologies
Under Investigation
Tissue-Type or Cell-Type Attacked
Under Investigation
Treatment(s)
Under Investigation
Managing Specialist(s)
Under Investigation
Research Authors
Under Investigation
Research Institutions
Under Investigation
Average Time from Symptom Onset to Diagnosis
Under Investigation
Last Updated
September 05, 2023
References
Chang R, Yen-Ting Chen T, Wang SI, Hung YM, Chen HY, Wei CJ. Risk of autoimmune diseases in patients with COVID-19: A retrospective cohort study. EClinicalMedicine. 2023 Feb;56:101783. doi: 10.1016/j.eclinm.2022.101783. Epub 2023 Jan 10. PMID: 36643619; PMCID: PMC9830133.
Ulcerative colitis. Autoimmune Association. (2022, September 16). Retrieved October 13, 2022, from https://autoimmune.org/disease-information/ulcerative-colitis-uc/